Matinas BioPharma Holdings (MTNB) Return on Sales (2015 - 2023)
Matinas BioPharma Holdings (MTNB) posted quarterly Return on Sales of 0.25% for Q4 2023, up 13.0% year-over-year from 0.22% in Q4 2022, and up 12.92% quarter-over-quarter from 0.28% in Q3 2023.
Matinas BioPharma Holdings (MTNB) Return on Sales (2015 - 2023) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Return on Sales for 9 consecutive years, with 0.25% the latest figure, recorded in Q4 2023.
- In Q4 2023, Return on Sales rose 13.0% year-over-year to 0.25%; the TTM figure through Dec 2023 stood at 0.25% (down 2.0% YoY), while the FY2023 annual figure was 0.21%, down 2.0% from the prior year.
- Return on Sales improved to 0.25% in Q4 2023 per MTNB's latest filing, from 0.28% in the prior quarter.
- Across five years, Return on Sales topped out at 1133.25% in Q4 2021 and bottomed at 7.58% in Q2 2021.
- Historically, Return on Sales has averaged 71.07% across 5 years, with a median of 0.26% in 2023.
- Annual changes were most pronounced in 2021 — Return on Sales surged 112821 bps — and 2022, when it slumped 113363 bps.
- Matinas BioPharma Holdings' Return on Sales stood at 5.34% in 2019, then surged by 194 bps to 5.04% in 2020, then jumped by 22370 bps to 1133.25% in 2021, then sank by 100 bps to 0.38% in 2022, then jumped by 35 bps to 0.25% in 2023.
- Business Quant data shows MTNB's Return on Sales at 0.25% in Q4 2023, 0.28% in Q3 2023, and 0.1% in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Matinas BioPharma Holdings | 1.19 Mn | 375,426.61 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.25% |
| Sep 30, 2023 | -0.28% |
| Jun 30, 2023 | -0.10% |
| Mar 31, 2023 | -0.18% |
| Dec 31, 2022 | -0.38% |
| Sep 30, 2022 | -0.10% |
| Jun 30, 2022 | -0.11% |
| Dec 31, 2021 | 1,133.25% |
| Sep 30, 2021 | 19.56% |
| Jun 30, 2021 | -7.58% |
| Mar 31, 2021 | -2.25% |
| Dec 31, 2020 | 5.04% |
| Sep 30, 2020 | -0.58% |
| Dec 31, 2019 | -5.34% |
| Sep 30, 2019 | -2.97% |
| Jun 30, 2019 | -0.67% |
| Dec 31, 2018 | -1.47% |
| Sep 30, 2018 | -1.10% |
| Jun 30, 2018 | -0.46% |
| Mar 31, 2018 | -1.61% |